1 0

    FDA 483 for Shire Human Genetic Therapies Inspection Ending Mar 23, 2022 (FEI 3009340644)

    FDA 483 for Shire Human Genetic Therapies Inspection Ending Mar 23, 2022 (FEI 3009340644)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: To Whom it May Concern: As permitted by the Freedom of Information Act (FOIA), I am hereby requesting the following document: Form FDA 483: Shire Human Genetic Therapies, Inc. Lexington United States End Dates of inspection: 23 Mar 2022 Project Area: Drug Quality Assurance FEI: 3009340644 Investigator(s):Wayne E Seifert, Charles Yuanchia Kuo, PhD, Scott C Lute Classification: VAI
    Tags: Pharma, 483, 2022
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details